Jiangsu Hualv Biological Technology Co.Ltd. (300970) — Cash Flow Quality Index
Jiangsu Hualv Biological Technology Co.Ltd. (300970) has a Cash Flow Quality Index of 3.13x as of December 2025. Operating cash flow of CN¥345.31 Million exceeds net income of CN¥110.27 Million, indicating high earnings quality where cash backs reported profits. Also explore 300970 total asset value for the complete picture of this company's asset base.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Jiangsu Hualv Biological Technology Co.Ltd. Cash Flow Quality Index (2019–2025)
Historical Cash Flow Quality Index for Jiangsu Hualv Biological Technology Co.Ltd. across 6 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check 300970 intangible-adjusted equity ratio to evaluate the tangible quality of the company's equity base.
Annual Cash Flow Quality Index for Jiangsu Hualv Biological Technology Co.Ltd. (2019–2025)
Year-by-year earnings quality comparison for Jiangsu Hualv Biological Technology Co.Ltd.. For live market cap and the full company financial profile, see Jiangsu Hualv Biological Technology Co.L market cap and net worth.
| Year | Quality Index | Operating CF (CNY) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 3.13x | CN¥345.31 Million | CN¥110.27 Million | ▼ -43.0% |
| 2023 | 5.49x | CN¥166.67 Million | CN¥30.35 Million | ▲ +139.0% |
| 2022 | 2.30x | CN¥179.84 Million | CN¥78.25 Million | ▼ -57.1% |
| 2021 | 5.36x | CN¥83.08 Million | CN¥15.50 Million | ▲ +256.6% |
| 2020 | 1.50x | CN¥199.09 Million | CN¥132.50 Million | ▼ -15.3% |
| 2019 | 1.77x | CN¥213.96 Million | CN¥120.67 Million | — |